INZY Projected Dividend Yield
Inozyme Pharma Inc ( NASDAQ : INZY )Inozyme Pharma is a rare disease biopharmaceutical company developing therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. Co.'s product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in the mineralization pathway caused by ectonucleotide pyrophosphatase/phosphodiesterase 1 and adenosine triphosphate-Binding Cassette in the C6 Deficiencies. This pathway is central to the regulation of calcium deposition throughout the body and is further associated with neointimal proliferation, or the overgrowth of smooth muscle cells inside blood vessels. 20 YEAR PERFORMANCE RESULTS |
INZY Dividend History Detail INZY Dividend News INZY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |